2162 fundamentals
KEYMED BIOSCIENCES INC financial statements, including revenue, expenses, profit, and loss
The total revenue of 2162 for the last semiannual is 59.25 M HKD, and it's 103.36% higher compared to the previous semiannual. The net income of H1 24 is -364.90 M HKD.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: HKD
TTM